Document

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No.     )
 
Filed by the Registrant                               Filed by a Party other than the Registrant  
Check the appropriate box:
 
Preliminary Proxy Statement
  
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
  
Definitive Proxy Statement
  
Definitive Additional Materials
  
Soliciting Material pursuant to §240.14a-12
Oyster Point Pharma, Inc.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
  
No fee required.
  
Fee paid previously with preliminary materials.
  
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.
   
 
 




https://cdn.kscope.io/fc2ec7df29617a1b7ddd53d02b79aad0-image_0.jpg



https://cdn.kscope.io/fc2ec7df29617a1b7ddd53d02b79aad0-image_1.jpg